APDN
Price
$2.39
Change
-$0.49 (-17.01%)
Updated
Sep 5 closing price
Capitalization
1.49M
PRPO
Price
$17.74
Change
+$1.64 (+10.19%)
Updated
Sep 5 closing price
Capitalization
28.73M
Interact to see
Advertisement

APDN vs PRPO

Header iconAPDN vs PRPO Comparison
Open Charts APDN vs PRPOBanner chart's image
Applied DNA Sciences
Price$2.39
Change-$0.49 (-17.01%)
Volume$460.48K
Capitalization1.49M
Precipio
Price$17.74
Change+$1.64 (+10.19%)
Volume$33.31K
Capitalization28.73M
APDN vs PRPO Comparison Chart in %
Loading...
APDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRPO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APDN vs. PRPO commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APDN is a Hold and PRPO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (APDN: $2.39 vs. PRPO: $17.74)
Brand notoriety: APDN and PRPO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: APDN: 359% vs. PRPO: 226%
Market capitalization -- APDN: $1.49M vs. PRPO: $28.73M
APDN [@Medical Specialties] is valued at $1.49M. PRPO’s [@Medical Specialties] market capitalization is $28.73M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APDN’s FA Score shows that 1 FA rating(s) are green whilePRPO’s FA Score has 1 green FA rating(s).

  • APDN’s FA Score: 1 green, 4 red.
  • PRPO’s FA Score: 1 green, 4 red.
According to our system of comparison, PRPO is a better buy in the long-term than APDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APDN’s TA Score shows that 3 TA indicator(s) are bullish while PRPO’s TA Score has 4 bullish TA indicator(s).

  • APDN’s TA Score: 3 bullish, 2 bearish.
  • PRPO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, APDN is a better buy in the short-term than PRPO.

Price Growth

APDN (@Medical Specialties) experienced а -26.69% price change this week, while PRPO (@Medical Specialties) price change was +14.30% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.01%. For the same industry, the average monthly price growth was +8.25%, and the average quarterly price growth was +13.64%.

Industries' Descriptions

@Medical Specialties (+1.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRPO($28.7M) has a higher market cap than APDN($1.5M). PRPO YTD gains are higher at: 220.228 vs. APDN (-98.438). PRPO has higher annual earnings (EBITDA): -1.45M vs. APDN (-13.08M). APDN has more cash in the bank: 4.73M vs. PRPO (1.02M). APDN has less debt than PRPO: APDN (334K) vs PRPO (2.23M). PRPO has higher revenues than APDN: PRPO (20M) vs APDN (3.74M).
APDNPRPOAPDN / PRPO
Capitalization1.5M28.7M5%
EBITDA-13.08M-1.45M903%
Gain YTD-98.438220.228-45%
P/E Ratio0.00N/A-
Revenue3.74M20M19%
Total Cash4.73M1.02M465%
Total Debt334K2.23M15%
FUNDAMENTALS RATINGS
APDN vs PRPO: Fundamental Ratings
APDN
PRPO
OUTLOOK RATING
1..100
536
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
9736
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APDN's Valuation (19) in the Information Technology Services industry is in the same range as PRPO (28) in the Biotechnology industry. This means that APDN’s stock grew similarly to PRPO’s over the last 12 months.

APDN's Profit vs Risk Rating (100) in the Information Technology Services industry is in the same range as PRPO (100) in the Biotechnology industry. This means that APDN’s stock grew similarly to PRPO’s over the last 12 months.

PRPO's SMR Rating (96) in the Biotechnology industry is in the same range as APDN (100) in the Information Technology Services industry. This means that PRPO’s stock grew similarly to APDN’s over the last 12 months.

PRPO's Price Growth Rating (36) in the Biotechnology industry is somewhat better than the same rating for APDN (97) in the Information Technology Services industry. This means that PRPO’s stock grew somewhat faster than APDN’s over the last 12 months.

APDN's P/E Growth Rating (96) in the Information Technology Services industry is in the same range as PRPO (100) in the Biotechnology industry. This means that APDN’s stock grew similarly to PRPO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APDNPRPO
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 30 days ago
77%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
APDN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRPO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMEC1.800.04
+2.56%
Primech Holdings Ltd
QGEN47.550.51
+1.08%
Qiagen N.V.
HOVNP20.000.10
+0.50%
Hovnanian Enterprises
CMPO18.50-0.06
-0.32%
CompoSecure
OBE5.84-0.20
-3.31%
Obsidian Energy Ltd

APDN and

Correlation & Price change

A.I.dvisor tells us that APDN and UFPT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APDN and UFPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APDN
1D Price
Change %
APDN100%
-17.01%
UFPT - APDN
29%
Poorly correlated
-0.75%
POAI - APDN
28%
Poorly correlated
-1.13%
CODX - APDN
28%
Poorly correlated
+0.29%
PRPO - APDN
27%
Poorly correlated
+10.19%
ATEC - APDN
24%
Poorly correlated
-0.91%
More